Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: Inflammation and oxidative stress

Abstract

In recent years, the risk, such as hypertension, obesity and diabetes mellitus, of cardiovascular diseases has been increasing explosively with the development of living conditions and the expansion of social psychological pressure. The disturbance of glucose and lipid metabolism contributes to both collapse of myocardial structure and cardiac dysfunction, which ultimately leads to diabetic cardiomyopathy. The pathogenesis of diabetic cardiomyopathy is multifactorial, including inflammatory cascade activation, oxidative/nitrative stress, and the following impaired Ca2+ handling induced by insulin resistance/hyperinsulinemia, hyperglycemia, hyperlipidemia in diabetes. Some key alterations of cellular signaling network, such as translocation of CD36 to sarcolemma, activation of NLRP3 inflammasome, up-regulation of AGE/RAGE system, and disequilibrium of micro-RNA, mediate diabetic oxidative stress/inflammation related myocardial remodeling and ventricular dysfunction in the context of glucose and lipid metabolic disturbance. Here, we summarized the detailed oxidative stress/inflammation network by which the abnormality of glucose and lipid metabolism facilitates diabetic cardiomyopathy.

Insights into Pathogenesis, Nutritional and Drug Approach in Sarcopenia: A Systematic Review

“…Altering mitochondrial function and biogenesis by increasing ROS production generates more inflammation, promoting increased activity of NLRP3 (pyrin domain of the Nod 3-like receptor family) that participates in sarcopenia [54,[62][63][64]. TNF-α activates local vascular endothelial cells, which causes the release of NO (nitric oxide), resulting in increased vascular permeability, allowing the passage of pro-inflammatory cells, and triggering excessive inflammation.…”

“…Sarcopenia can contribute to the development and progression of T2DM due to the reduction of muscle mass and uptake of glucose, and the increase in localized inflammation, which can arise through inter and intramuscular adipose tissue accumulation. Furthermore, the increase in adipose tissue favors the production of several cytokines that increase muscle catabolism [64,80,81].…”

Study on the mechanism of Wumei San in treating piglet diarrhea using network pharmacology and molecular docking

“…GO enrichment analysis showed that WMS may play a therapeutic role by regulating the immune response of piglets, modulating cell growth, and regulating apoptosis. PD is caused by impaired intestinal barrier function, disruption of intestinal flora homeostasis, and disturbances in intestinal chemical, mechanical, and immune barriers (48,49). The impaired intestinal barriers may promote bacterial translocation and the entry of allergic compounds from the intestine into the body, leading to increased immune response and susceptibility.…”

The protection of luteolin against diabetic cardiomyopathy in rats is related to reversing JNK-suppressed autophagy

“…Diabetic cardiomyopathy (DCM), characterized by myocardial hypertrophy, fibrosis and dysfunction independent of coronary artery disease, hypertension, or congenital heart disease, contributes to the high mortality in diabetes. 1,2 Autophagy is required for cardiomyocyte homeostasis under both basal and stress conditions to maintain normal structure and function. 3,4 Common markers of autophagy include double-membrane vesicles such as autophagosomes and autophagosome-lysosomes, autophagic flux, microtubuleassociated protein 1 light chain 3 (LC3), the ratio of the active LC3-II to the inactive LC3-I, and expressions of autophagyrelated genes such as sequestosome 1 ( p62), beclin-1 and autophagy proteins.…”

“…Diabetic cardiomyopathy (DCM), characterized by myocardial hypertrophy, fibrosis and dysfunction independent of coronary artery disease, hypertension, or congenital heart disease, contributes to the high mortality in diabetes. 1,2…”